Acquired Stada To Act As 'Core' For Future Bain and Cinven Bolt-Ons
Executive Summary
Cinven and Bain seem likely to use German generics maker Stada as a nucleus around which to add smaller acquisitions, mostly in Europe, for an eventual exit by the private equity firms.
You may also be interested in...
Try, Try Again: Bain And Cinven File Fresh Bid For Stada
Stada is likely to approve a second takeover bid from equity groups Bain and Cinven soon, at a new price of €66.25 per share; an offer cleared by Germany's stock market authorities despite a ban in the country on repeat acquisition bids within 12 months.
Try, Try Again: Bain And Cinven File Fresh Bid For Stada
Stada is likely to approve a second takeover bid from equity groups Bain and Cinven soon, at a new price of €66.25 per share; an offer cleared by Germany's stock market authorities despite a ban in the country on repeat acquisition bids within 12 months.
Stada CEO & CFO Resign; Rumors Circle Of A New Takeover bid
Stada's top brass have quit following rumors earlier this week of a fresh takeover bid for the generic company from equity groups Bain and Cinven; ex-Boehringer executive Tjeenk Willink has been named incoming CEO.